Guggenheim reiterates Buy rating on Johnson & Johnson stock

Investing.comWednesday, October 8, 2025 at 11:41:10 AM
Guggenheim reiterates Buy rating on Johnson & Johnson stock
Guggenheim has reaffirmed its Buy rating on Johnson & Johnson stock, signaling confidence in the company's future performance. This endorsement is significant as it reflects the firm's belief in Johnson & Johnson's strong fundamentals and growth potential, which could attract more investors and positively influence the stock market.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Guggenheim initiates CG Oncology stock with Buy rating, $90 price target
PositiveFinancial Markets
Guggenheim has initiated coverage of CG Oncology with a Buy rating and set a price target of $90. This positive outlook reflects confidence in CG Oncology's potential for growth and success in the market, which could attract investors looking for promising opportunities in the biotech sector.
Guggenheim initiates coverage on Olema Pharmaceuticals stock with Buy rating
PositiveFinancial Markets
Guggenheim has started coverage on Olema Pharmaceuticals, giving it a 'Buy' rating. This is significant as it reflects confidence in Olema's potential for growth and success in the pharmaceutical market, which could attract more investors and boost the company's stock performance.
Johnson & Johnson Ordered to Pay $966 Million in Latest Talc Lawsuit
NegativeFinancial Markets
In a significant legal ruling, Johnson & Johnson has been ordered to pay $966 million in a lawsuit linked to its talc powder products, which were claimed to have caused a California woman's death from mesothelioma, a rare cancer. This decision is particularly impactful as it follows a recent rejection of the company's bankruptcy plan aimed at settling ongoing and future lawsuits related to its talc products. The outcome highlights ongoing concerns about the safety of talc-based products and the legal challenges facing the company.
Guggenheim raises Adicet Bio stock price target on positive lupus data
PositiveFinancial Markets
Guggenheim has raised its stock price target for Adicet Bio following promising data related to lupus treatment. This is significant as it reflects growing confidence in Adicet's potential to address a challenging autoimmune condition, which could lead to increased investment and interest in the biotech sector. Positive developments like this can boost not only the company's stock but also the overall market sentiment towards innovative therapies.
Johnson & Johnson ordered to pay $966 million in talc cancer case after jury finds company liable
NegativeFinancial Markets
In a significant legal ruling, Johnson & Johnson has been ordered to pay $966 million after a jury found the company liable in a talc cancer case. This decision highlights the ongoing concerns surrounding the safety of talcum powder products and their potential link to cancer, affecting countless consumers and raising questions about corporate responsibility. The outcome of this case could set a precedent for future lawsuits and impact the company's reputation and financial standing.
Johnson & Johnson ordered to pay $966 million in baby powder case
NegativeFinancial Markets
Johnson & Johnson has been ordered to pay a staggering $966 million in a lawsuit related to its baby powder product. This ruling highlights ongoing concerns about the safety of talc-based products and their potential link to cancer. The case is significant as it reflects the growing scrutiny on major corporations regarding consumer safety and accountability, potentially impacting public trust and future sales.
Guggenheim reiterates Buy rating on Spyre stock, maintains $65 price target
PositiveFinancial Markets
Guggenheim has reaffirmed its Buy rating on Spyre stock, maintaining a price target of $65. This endorsement is significant as it reflects confidence in Spyre's growth potential and market performance, which could attract more investors and positively influence the stock's trajectory.
Guggenheim initiates Via Transportation stock with Buy rating, $58 target
PositiveFinancial Markets
Guggenheim has initiated coverage of Via Transportation with a Buy rating and set a target price of $58. This positive outlook reflects confidence in Via's growth potential and market position, making it an attractive option for investors looking for promising opportunities in the transportation sector.
Johnson & Johnson stock price target raised to $200 from $195 at Wolfe Research
PositiveFinancial Markets
Wolfe Research has raised its stock price target for Johnson & Johnson from $195 to $200, reflecting a positive outlook for the company. This adjustment indicates confidence in Johnson & Johnson's future performance and could attract more investors, potentially boosting the stock's value. Such changes in price targets are significant as they can influence market perceptions and investment decisions.
Latest from Financial Markets
Tesla Unveils New Models for Under $40,000
PositiveFinancial Markets
Tesla has just unveiled new electric vehicle models priced under $40,000, which could make EVs more accessible to a broader audience. This move is significant as it may attract new customers while potentially impacting the sales of Tesla's premium models, according to former board member Steve Westly. As the market for affordable electric vehicles grows, Tesla's strategy could reshape the competitive landscape in the automotive industry.
Who Is Alexandr Wang? The 28-Year-Old AI Billionaire Mark Zuckerberg Just Paid $14 Billion to Lead Meta’s ‘Superintelligence Labs’
PositiveFinancial Markets
Alexandr Wang, a 28-year-old tech prodigy and founder of Scale AI, has been appointed by Mark Zuckerberg to lead Meta's new Superintelligence Labs with a staggering $14 billion investment. This move signifies Meta's commitment to advancing artificial intelligence and positions Wang at the forefront of innovation in the tech industry. His leadership is expected to drive significant advancements in AI technology, making this a pivotal moment for both Meta and the future of AI.
Meet the rural school district that used H-1B visas to hire Filipino teachers because ‘we quite simply didn’t have other applicants’
PositiveFinancial Markets
In a unique approach to address teacher shortages, a rural school district in South Dakota has successfully utilized H-1B visas to hire Filipino teachers. Superintendent Rob Coverdale emphasized that these teachers are not taking jobs from Americans but are filling crucial positions that would otherwise remain vacant. This initiative highlights the district's commitment to providing quality education despite challenges in attracting local applicants, showcasing a proactive solution to a pressing issue in rural education.
Etsy’s SWOT analysis: handmade marketplace stock faces growth challenges
NegativeFinancial Markets
Etsy is facing significant growth challenges as highlighted in its recent SWOT analysis. The handmade marketplace, known for its unique products, is struggling to maintain its stock performance amidst increasing competition and changing consumer preferences. This matters because it reflects broader trends in e-commerce and could impact the livelihoods of many small sellers who rely on the platform for their businesses.
The latest used and new car buying trends you should know about
NeutralFinancial Markets
As we move into the latter half of the year, car buyers and manufacturers are changing their strategies in the automotive market. This shift is significant as it reflects evolving consumer preferences and market dynamics, which could impact pricing and availability for both new and used vehicles.
Most Fed members see further rate cuts this year amid labor market softness
PositiveFinancial Markets
Recent discussions among Federal Reserve members indicate a consensus on the likelihood of further rate cuts this year, primarily due to ongoing softness in the labor market. This is significant as it reflects the Fed's proactive approach to stimulate economic growth and combat inflation, which could lead to more favorable borrowing conditions for consumers and businesses alike.